Axcella to Hold Virtual-Only 2020 Annual Meeting of Stockholders
May 04 2020 - 4:05PM
Business Wire
Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company
focused on leveraging endogenous metabolic modulators (EMMs) to
pioneer a new approach for treating complex diseases and improving
health, today announced that its 2020 Annual Meeting of
Stockholders will be held in a virtual-only format due to the
continued public health impact of the coronavirus outbreak
(COVID-19) and to support the health and well-being of its
employees, stockholders and community. The previously announced
date and time of the meeting, Wednesday, May 20, 2020 at 9:00 a.m.
Eastern Time, will not change. The virtual annual meeting can be
accessed at the following link: www.meetingcenter.io/253043808. The
password for the meeting is AXLA2020.
To log in to the virtual annual meeting, you have two options:
join as a “Guest” or join as a “Stockholder.” If you were a
stockholder as of the close of business on March 27, 2020, you are
eligible to join the virtual annual meeting as a “Stockholder” and
have the option to vote your shares or ask questions at the
meeting.
To join the virtual annual meeting as a “Stockholder,” you will
be required to enter your control number. If you are a registered
stockholder, the control number can be found on your proxy card or
notice, or in the email you previously received. If you hold your
shares through an intermediary, such as a bank or broker, you must
register in advance to obtain a control number. To register, you
must submit proof of your proxy power (legal proxy) reflecting your
Axcella Health Inc. holdings along with your name and email address
to Computershare. Requests for registration should be labeled as
“Legal Proxy” and directed to Computershare by forwarding the email
from your bank or broker with the legal proxy, or by sending an
image of your legal proxy to legalproxy@computershare.com. Requests
for registration must be received no later than 5:00 p.m. Eastern
Time on Friday, May 15, 2020.
If you do not have your control number, you may attend as a
“Guest” but will not have the option to vote your shares or ask
questions at the virtual annual meeting.
About Axcella Axcella is a clinical-stage biotechnology
company focused on leveraging endogenous metabolic modulators
(EMMs) to pioneer a new approach for treating complex diseases and
improving health. The company’s product candidates are comprised of
EMMs and their derivatives that are engineered in distinct
combinations and ratios to simultaneously impact multiple
biological pathways. Axcella’s pipeline includes lead therapeutic
candidates for non-alcoholic steatohepatitis (NASH) and the
prevention of in risk of overt hepatic encephalopathy (OHE)
recurrence. Additional muscle- and blood-related programs are in
earlier-stage development. For more information, please visit
www.axcellahealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200504005463/en/
Company/Investor Contact Jason Fredette
jfredette@axcellahealth.com 857.320.2236
Media Contact Azeem Zeekrya HDMZ azeem.zeekrya@hdmz.com
312-506-5244
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Apr 2023 to Apr 2024